Goldman Sachs’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-194,533
| Closed | -$574K | – | 5262 |
|
|
2024
Q4 | $574K | Buy |
194,533
+18,272
| +10% | +$53.9K | ﹤0.01% | 4227 |
|
|
2024
Q3 | $531K | Buy |
176,261
+1,279
| +0.7% | +$3.85K | ﹤0.01% | 4085 |
|
|
2024
Q2 | $609K | Buy |
174,982
+8,818
| +5% | +$30.7K | ﹤0.01% | 3853 |
|
|
2024
Q1 | $877K | Buy |
166,164
+2,376
| +1% | +$12.5K | ﹤0.01% | 3695 |
|
|
2023
Q4 | $842K | Buy |
+163,788
| New | +$842K | ﹤0.01% | 3698 |
|
|
2023
Q3 | – | Sell |
-57,316
| Closed | -$107K | – | 4956 |
|
|
2023
Q2 | $107K | Buy |
57,316
+54,060
| +1,660% | +$101K | ﹤0.01% | 4554 |
|
|
2023
Q1 | $12.2K | Sell |
3,256
-499
| -13% | -$1.87K | ﹤0.01% | 4933 |
|
|
2022
Q4 | $11.6K | Sell |
3,755
-1,073
| -22% | -$3.32K | ﹤0.01% | 4933 |
|
|
2022
Q3 | $22K | Sell |
4,828
-17,825
| -79% | -$81.2K | ﹤0.01% | 5150 |
|
|
2022
Q2 | $598K | Buy |
22,653
+794
| +4% | +$21K | ﹤0.01% | 4266 |
|
|
2022
Q1 | $813K | Sell |
21,859
-17,856
| -45% | -$664K | ﹤0.01% | 4264 |
|
|
2021
Q4 | $2.32M | Sell |
39,715
-14,427
| -27% | -$844K | ﹤0.01% | 3397 |
|
|
2021
Q3 | $4.45M | Buy |
54,142
+34,645
| +178% | +$2.85M | ﹤0.01% | 2867 |
|
|
2021
Q2 | $1.84M | Buy |
19,497
+11,887
| +156% | +$1.12M | ﹤0.01% | 3584 |
|
|
2021
Q1 | $486K | Buy |
7,610
+4,804
| +171% | +$307K | ﹤0.01% | 4380 |
|
|
2020
Q4 | $163K | Sell |
2,806
-1,906
| -40% | -$111K | ﹤0.01% | 4341 |
|
|
2020
Q3 | $99K | Buy |
+4,712
| New | +$99K | ﹤0.01% | 4234 |
|
|
2016
Q4 | – | Sell |
-406
| Closed | -$51K | – | 4573 |
|
|
2016
Q3 | $51K | Buy |
+406
| New | +$51K | ﹤0.01% | 4304 |
|